NIH-funded research R01 grant

Understanding genetic factors in mental disorders using advanced algorithms

Official title: Delineating the network effects of mental disorder-associated variants using convex optimization methods

Funded at New York Genome Center · NIH-11093320 · Data updated 2026-11-12

This study is looking at the genes linked to conditions like autism and bipolar disorder to help us understand what makes them happen, which could lead to better treatments for people living with these challenges.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York Genome Center
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2022
Project endMay 31, 2027
Funding year2025
Award (this year)$773,033
NIH project number5R01MH130879-04
Project IDNIH-11093320 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with autism spectrum disorder or bipolar disorder.

Less likely to help

Patients with neuropsychiatric disorders not included in the study's focus may not receive direct benefits from this research.

What this research studies

This research investigates the genetic components associated with neuropsychiatric disorders, such as autism and bipolar disorder, by analyzing large datasets from genome-wide studies. Using advanced mathematical techniques, the researchers aim to identify shared and unique genetic traits that contribute to these conditions. The study employs convex optimization methods to ensure efficient computation and reliable results, which could lead to a better understanding of the biological mechanisms behind these disorders. Patients may benefit from insights that could inform future treatments and interventions.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with neuropsychiatric disorders.

How similar studies have gone: Previous research using similar genetic analysis methods has shown promise in identifying genetic factors related to mental health conditions.

Where this research is happening

  • New York Genome Center
    New York, United States
    Active

Researchers

  • Principal investigator: Knowles, David Arthur — New York Genome Center
  • Study coordinator: Knowles, David Arthur

Related research

Other NIH-funded projects on the same topics.

  • Understanding genetic networks in autism and bipolar disorders to improve biology and treatment

    A research grant will study how genetic factors influence autism and bipolar disorder by using advanced math and large genetic datasets to map networks in the brain.

    NIH research New York Genome Center · New York, United States · NIH-11352565

  • Virtual approaches for period pain in young women

    This study tests two online self-care options—auricular acupressure and Baduanjin qigong—against a self-care education group to see if they reduce menstrual pain and related symptoms in young women.

    Recruiting Phase 2/3 Nanyang Technological University · Singapore · NCT07497711

  • Outcomes of Strategic Psychotherapy for Adults in Private Practice

    This project will see if brief Strategic Psychotherapy helps adults with diagnosed mental disorders who seek private outpatient care improve symptoms and everyday functioning.

    Recruiting at 2 sites Società Scientifica di Psicoterapia Strategica · Empoli, Italy and 1 other locations · NCT07195266

  • Connectivity-guided theta-burst stimulation targeting the hippocampus in schizophrenia

    We will try targeted theta-burst TMS guided by brain connectivity to change hippocampus activity in adults with schizophrenia or related psychotic disorders, measuring brain signals with EEG and, for some participants, intracranial electrodes.

    Recruiting Stanford University · Stanford, California · NCT07010614

  • Genetic-guided psychotropic medication choices for adults in Manitoba

    This project will test whether using a patient's genetics to guide psychotropic medication choices helps adults in Manitoba who are starting or changing psychiatric medicines.

    Recruiting University of Manitoba · Winnipeg, Manitoba and 1 other locations · NCT06929533

  • Digital program to reduce depression and cannabis use

    This trial will test a digital program called AMP-C to see if it reduces depressive symptoms and cannabis use in adults with both major depression and problematic cannabis use.

    Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT06878859

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.